Back to search

Article

How to Demonstrate the Glucose Specificity of a Non-Invasive CGM: A Case Study of the SKAMo-2 Clinical Trial and Neogly™

2026-08-18

Abstract excerpt

<h4>Background</h4> Every non-invasive continuous glucose monitoring (NI-CGM) technology introduced into the landscape faces the same skeptical question, from regulators, clinicians, and competing developers alike: is the candidate signal actually specific to glucose, or does an apparently reasonable accuracy figure simply reflect a model fitting to motion, temperature, calibration offset, or trial-duration artif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ea7e1ea-65df-5933-8b51-04266f689fd4
DOI
10.64898/2026.08.17.26360581
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
How to Demonstrate the Glucose Specificity of a Non-Invasive CGM: A Case Study of the SKAMo-2 Clinical Trial and Neogly™DOI 10.64898/2026.08.17.26360581
Select a neighboring publication to make it the new centre.